Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
Investigational New Drugs
|
June 12, 2014
A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neck
Daniel W Bowles, Neil Senzer, Diana Hausman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 6, 2016
Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery
Zhaohui Wang, Christopher M Jay, Courtney Evans, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 12, 2016
Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma
Donald D Rao, Christopher Jay, Zhaohui Wang, et al.
Cancer Gene Therapy
|
September 23, 2003
Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients
John Nemunaitis, Casey Cunningham, Neil Senzer, et al.
Oncology
|
July 2, 2019
Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience
Matthew N Metzinger, Cherian Verghese, Danae M Hamouda, et al.
Plos One
|
June 1, 2018
KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex
Donald D Rao, Xiuquan Luo, Zhaohui Wang, et al.
Gene Regulation and Systems Biology
|
September 30, 2009
Preclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2)
Chris Jay, Gregory Nemunaitis, John Nemunaitis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
A phase I dose-escalation study of Tivantinib (ARQ 197) in adult patients with metastatic solid tumors
Lee S Rosen, Neil Senzer, Tarek Mekhail, et al.
Cancer Investigation
|
September 20, 2006
Phase I trial of PT-100 (PT-100), a cytokine-inducing small molecule, following chemotherapy for solid tumor malignancy
John Nemunaitis, Svetislava J Vukelja, Donald Richards, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 24, 2013
Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors
Neil Senzer, John Nemunaitis, Derek Nemunaitis, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
Investigational New Drugs
|
June 12, 2014
A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neck
Daniel W Bowles, Neil Senzer, Diana Hausman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
November 6, 2016
Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery
Zhaohui Wang, Christopher M Jay, Courtney Evans, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 12, 2016
Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma
Donald D Rao, Christopher Jay, Zhaohui Wang, et al.
Cancer Gene Therapy
|
September 23, 2003
Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients
John Nemunaitis, Casey Cunningham, Neil Senzer, et al.
Oncology
|
July 2, 2019
Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience
Matthew N Metzinger, Cherian Verghese, Danae M Hamouda, et al.
Plos One
|
June 1, 2018
KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex
Donald D Rao, Xiuquan Luo, Zhaohui Wang, et al.
Gene Regulation and Systems Biology
|
September 30, 2009
Preclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2)
Chris Jay, Gregory Nemunaitis, John Nemunaitis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
A phase I dose-escalation study of Tivantinib (ARQ 197) in adult patients with metastatic solid tumors
Lee S Rosen, Neil Senzer, Tarek Mekhail, et al.
Cancer Investigation
|
September 20, 2006
Phase I trial of PT-100 (PT-100), a cytokine-inducing small molecule, following chemotherapy for solid tumor malignancy
John Nemunaitis, Svetislava J Vukelja, Donald Richards, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 24, 2013
Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors
Neil Senzer, John Nemunaitis, Derek Nemunaitis, et al.
Page
of 8